Skip to content
NBlaz – Lifestyle
Author:
Mestag Therapeutics Ltd.
Mestag Therapeutics to Present Data on Targeted LTBR Agonist MST-0312 at Cancer Immunotherapy Keystone Symposia
March 12, 2026